echothiophate iodide (Phospholine iodide)
Jump to navigation
Jump to search
Introduction
Tradename: Phospholine iodide.
Indications
Dosage
Solution: 0.03%, 0.06%, 0.125%, 0.25% (5 mL).
Adverse effects
- not common (1-10%)
- uncomon (< 1%)
- bradycardia, hypotension, flushing, dyspnea, retinal detachment, diaphoresis, muscle weakness, nausea/vomiting, diarrhea, browache, miosis, eyelid twitching, watery eyes
More general terms
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 1998
- ↑ Jump up to: 3.0 3.1 Deprecated Reference
- ↑ Department of Veterans Affairs, VA National Formulary